Therapeutic approaches: session XI summary and research needs.
Williams-Johnso
M
M
US Department of Health and Human Services, Division of Toxicology, Agency for Toxic Substances and Disease Registry, Atlanta, GA, USA. mwilliams-johnson@cdc.gov
Isacson
O
O
D000818:Animals; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D001921:Brain / Q000502:physiology; D004195:Disease Models, Animal; D004599:Electric Stimulation Therapy; D006801:Humans; D010300:Parkinson Disease / Q000235:genetics / Q000503:physiopathology / Q000601:surgery / Q000628:therapy*
D000978:Antiparkinson Agents